What medical and pharmaceutical/bioscience/medical device meeting planners and continuing medical education professionals need to know to plan meetings and CME activities for healthcare professionals.
Here's an interesting Q&A with Dr. Paul Woods, head of worldwide promotional regulatory affairs department for AstraZeneca, U.K., about the International Federation of Pharmaceutical Manufacturers' Association's pharma marketing code. A snip...
According to this USA Today article, a growing number of medical groups are insisting on holding their meetings only in cities and states with "smoke-free air" laws. A snip...
This article from Haaretz.com points to an interesting program developed by the head of medical classification in Israel's IDF, Lieutenant Colonel Arnon Ofek, and the Medical Instruction Center at Sheba Medical Center, Tel Hashomer. It is ...
Peter Gleason, MD, found himself in handcuffs recently for promoting an off-label use of a drug, according to this article in the New York Times. He is charged with promoting Xyrem, a narcolepsy drug from Jazz Pharmaceuticals, for depression and...
I have to brag about this one: Scott Raymond, our art director, won the Gold in the ASBPE Nationals for the Medical Meetings March/April 2005 cover, "Don't Panic," which was about the ACCME's updated Standards for Commercial Support. I think th...
Roche pharmaceuticals has been accused of violating Australia's pharmaceutical code of conduct by taking 200 docs out to swanky dinners that cost up to $200 a head (see story here. A snip...
I love this Mouse Party educational tool from the Genetic Science Learning Center at the University of Utah about how various types of drugs affect the brain. I hadn't seen anything quite like it before, and it made me want to go through and learn...
While I appreciate the sentiments expressed in this editorial, I'm just itching to write a letter to the editor explaining just how commercial support and CME really works. This is how Dr. Steele thinks it does...
